Cleared Traditional

K200884 - B-Secur HeartKey Software Library

K200884 is the FDA 510(k) clearance for B-Secur HeartKey Software Library by B-Secur , Ltd.. It is a Class 2 Cardiovascular device (product code DPS) cleared through the Traditional 510(k) pathway after a 249-day FDA review.

K200884 · B-Secur , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
249d
Days
Class 2
Risk

K200884 is an FDA 510(k) clearance for the B-Secur HeartKey Software Library. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by B-Secur , Ltd. (Belfast, GB). The FDA issued a Cleared decision on December 7, 2020 after a review of 249 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all B-Secur , Ltd. devices

Submission Details

510(k) Number K200884 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 02, 2020
Decision Date December 07, 2020
Days to Decision 249 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
124d slower than avg
Panel avg: 125d · This submission: 249d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

B-Secur Ltd. C/O Promedic, LLC
Paul Dryden

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DPS Electrocardiograph

All 248
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K200884.
electrocardiograph: SE-1202
K210140 · Edan Instruments, Inc. · Oct 2021
Page Writer TC20 Cardiograph, Page Writer TC30 Cardiograph, Page Writer TC50 Cardiograph, Page Writer TC70 Cardiograph
K210560 · Philips Medical Systems · Jun 2021
MAC 7 - Resting ECG Analysis System
K203786 · Ge Medical Systems Information Technologies, Inc. · Apr 2021
PageWriter TC20 Cardiograph, PageWriter TC30 Cardiograph, PageWriter TC50 Cardiograph, PageWriter TC70 Cardiograph
K191738 · Philips Medical Systems · Sep 2020
physIQ Heart Rhythm and Respiration Module
K193415 · Physiq, Inc. · Jun 2020
AI-ECG Tracker
K200036 · Shenzhen Carewell Electronics Co., Ltd. · Mar 2020